We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$51.2B
AUM Growth
+$4.14B
(+8.8%)
Cap. Flow
+$445M
Cap. Flow
% of AUM
0.87%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
3,234
New
648
Increased
710
Reduced
838
Closed
835
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.99B |
| 2 |
Microsoft
MSFT
|
+$522M |
| 3 |
Advanced Micro Devices
AMD
|
+$511M |
| 4 |
Amazon
AMZN
|
+$318M |
| 5 |
Apple
AAPL
|
+$317M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$402M |
| 2 |
McDonald's
MCD
|
+$375M |
| 3 |
Visa
V
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$319M |
| 5 |
Adobe
ADBE
|
+$272M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Healthcare | 17.11% |
| 3 | Consumer Discretionary | 13.31% |
| 4 | Financials | 8% |
| 5 | Industrials | 6.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2276
Traeger
COOK
$175M
| $118K | ﹤0.01% |
554
| – | – |
|
|
SACH
2277
Sachem Capital Corp
SACH
$38.8M
| $118K | ﹤0.01% |
33,690
-101,846
| -75% | -$344K |
|
2278
Cullinan Oncology
CGEM
$1.25B
| $117K | ﹤0.01% |
+10,837
| New | +$115K |
|
|
BIG
2279
DELISTED
Big Lots, Inc.
BIG
| $116K | ﹤0.01% |
+13,160
| New | +$112K |
|
2280
CoreCivic
CXW
$3.34B
| $116K | ﹤0.01% |
+12,342
| New | +$112K |
|
2281
AlTi Global
ALTI
$441M
| $115K | ﹤0.01% |
+14,998
| New | +$105K |
|
2282
CS Disco
LAW
$277M
| $114K | ﹤0.01% |
13,883
-11,370
| -45% | -$78K |
|
2283
UWM Holdings
UWMC
$2.34B
| $112K | ﹤0.01% |
+19,955
| New | +$107K |
|
2284
KNOT Offshore Partners
KNOP
$369M
| $110K | ﹤0.01% |
22,327
-23,125
| -51% | -$115K |
|
|
RERE
2285
ATRenew
RERE
$988M
| $110K | ﹤0.01% |
+37,550
| New | +$104K |
|
2286
CALL
P3 Health Partners Inc Warrant
PIIIW
$186K
| $109K | ﹤0.01% |
36,533
-14,820
| -29% | -$3.04K |
|
|
BFLY.WS
2287
CALL
DELISTED
Butterfly Network Inc Warrants
BFLY.WS
| $109K | ﹤0.01% |
47,317
-122,683
| -72% | -$31.7K |
|
2288
McEwen Inc
MUX
$1.17B
| $105K | ﹤0.01% |
+14,615
| New | +$118K |
|
|
RTB
2289
RTB Digital
RTB
$236M
| $104K | ﹤0.01% |
396
-145
| -27% | -$31.7K |
|
|
CDTX
2290
DELISTED
Cidara Therapeutics
CDTX
| $101K | ﹤0.01% |
4,466
+3,053
| +216% | +$71.7K |
|
2291
Atara Biotherapeutics
ATRA
$80.1M
| $100K | ﹤0.01% |
+2,487
| New | +$141K |
|
2292
CALL
iShares US Transportation ETF
IYT
$2.27B
| $99.9K | ﹤0.01% |
+1,600
| New | +$91.7K |
|
2293
Ovid Therapeutics
OVID
$483M
| $98.5K | ﹤0.01% |
+30,017
| New | +$102K |
|
|
CIO
2294
DELISTED
City Office REIT
CIO
| $97.9K | ﹤0.01% |
17,568
+1,498
| +9% | +$8.17K |
|
2295
Rimini Street
RMNI
$449M
| $97.5K | ﹤0.01% |
+20,350
| New | +$84.3K |
|
|
WE.WS
2296
CALL
DELISTED
WeWork Inc. Warrants, each exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
WE.WS
| $96.2K | ﹤0.01% |
370,000
-30,000
| -8% | -$1.04K |
|
2297
Destination XL Group
DXLG
$33.1M
| $95.3K | ﹤0.01% |
19,443
-211,147
| -92% | -$992K |
|
2298
Paysign
PAYS
$707M
| $94.9K | ﹤0.01% |
38,726
+7,346
| +23% | +$22.6K |
|
|
SAND
2299
DELISTED
Sandstorm Gold
SAND
| $92.9K | ﹤0.01% |
+18,150
| New | +$101K |
|
|
NOTV
2300
DELISTED
Inotiv
NOTV
| $92.1K | ﹤0.01% |
19,314
-6,386
| -25% | -$35.3K |
|
Similar funds
Marshall Wace's Q2 2023 Portfolio in Review
As of Q2 2023, Marshall Wace held 3,234 positions worth $51.2B, up 8.8% from $47.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Marshall Wace's Q2 2023 filing shows 648 new, 710 increased, 838 reduced and 835 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B. The largest sale was Gilead Sciences, an estimated $402M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Marshall Wace's largest Q2 2023 buy was iShares Core S&P 500 ETF: 4,713,944 shares worth $2.1B.
- Marshall Wace added most to Microsoft in Q2 2023, an estimated $522M increase.
- Marshall Wace's biggest Q2 2023 reduction was Gilead Sciences, cutting an estimated $402M.
- Marshall Wace fully exited Cloudflare in Q2 2023, selling an estimated $136M.
- Marshall Wace's ten largest holdings make up 20% of its $51.2B portfolio in Q2 2023.
- Marshall Wace opened 648 new positions and closed 835 in Q2 2023.
- Marshall Wace's portfolio value rose 8.8% quarter-over-quarter to $51.2B.
Based on Marshall Wace's 13F filing for Q2 2023, filed 14 Aug 2023.